Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features.
about
Biomarkers of head and neck cancer, tools or a gordian knot?Tumor and stromal-based contributions to head and neck squamous cell carcinoma invasionProtein N-glycosylation in oral cancer: dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signalingSheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transitionInhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancerEvidence for mesenchymal-like sub-populations within squamous cell carcinomas possessing chemoresistance and phenotypic plasticity.Elevated Src family kinase activity stabilizes E-cadherin-based junctions and collective movement of head and neck squamous cell carcinomas.Systems biology approach to identification of biomarkers for metastatic progression in cancer.SNAI1 expression and the mesenchymal phenotype: an immunohistochemical study performed on 46 cases of oral squamous cell carcinomaEpithelial-mesenchymal transition regulated by EphA2 contributes to vasculogenic mimicry formation of head and neck squamous cell carcinoma.Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinomaIntegration of biomarkers including molecular targeted therapies in head and neck cancer.An orthotopic murine model of sinonasal malignancy.Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasisCarnosic acid inhibits the epithelial-mesenchymal transition in B16F10 melanoma cells: a possible mechanism for the inhibition of cell migration.CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancerDownregulation of thrombomodulin, a novel target of Snail, induces tumorigenesis through epithelial-mesenchymal transition.miR-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth.A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment.FoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis.Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancerCelecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signalingClinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression.Identification of molecular signature of head and neck cancer stem-like cellsMarkers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinomaOpportunities and challenges facing biomarker development for personalized head and neck cancer treatment.Antroquinonol Targets FAK-Signaling Pathway Suppressed Cell Migration, Invasion, and Tumor Growth of C6 Glioma.Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met.Epithelial-mesenchymal transition-like events in vulvar cancer and its relation with HPV.A new perspective of vasculogenic mimicry: EMT and cancer stem cells (Review).c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPCAnalysis of clinicopathological characteristics associated with the outcome of oral squamous cell carcinoma and the establishment of tissue microarrays.Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors.Benzyl isothiocyanate inhibits HNSCC cell migration and invasion, and sensitizes HNSCC cells to cisplatin.TFIIB-related factor 2 is associated with poor prognosis of nonsmall cell lung cancer patients through promoting tumor epithelial-mesenchymal transition.Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways.The dual kinase complex FAK-Src as a promising therapeutic target in cancerSomatic evolution of head and neck cancer - biological robustness and latent vulnerability.
P2860
Q26784289-0B647644-9FE2-4134-B5BA-D92B4E42D410Q26825164-8D4653BF-9196-42ED-B538-A6F5610F5894Q26861795-C87D8A96-6A17-4F68-A926-06361E0AC911Q26864979-BD43942D-351D-4E54-9B80-A067D8B49E5BQ28488474-A8598948-A32C-4DEC-A959-16217503B927Q30498197-21E187F1-5925-4BD6-8B4D-BC961AA1E1BDQ30655673-487ADDAC-D642-4A82-A3BF-CC3A22B3D980Q33369631-513B9C1B-92D8-4A16-9A9B-FEAF4EF05CB0Q33533958-55E51A0B-386F-4181-A012-029E7182FCA9Q33594147-2E68B671-7ACC-4A7C-B76C-745477724E41Q33646333-18B5CD26-2480-45CB-860E-8BACD18BA9FEQ33674090-D742DFEC-B925-42FA-8DBB-FEE5DC8AA3E5Q33674587-B7201DC3-E3D9-4204-9A2C-E5FAAF972E67Q33884709-2E67DD2F-C6BE-4A1A-BAA4-7D5AACC5F433Q34072491-9CFCB992-951E-4135-B6A1-8A208D789723Q34091227-67BA1F71-A63C-4F20-A86B-80AF084D1778Q34178127-089B4F03-B4C5-48D7-92F7-6BAE3BE2A2C3Q34366475-486BFE8E-F465-439C-B42B-7BC31EE355F5Q34437862-71EF0A35-55F0-403B-96BF-39CA58BA48E8Q34639711-1DDC143C-D79A-427C-83B7-0A279E4CEA8FQ34684291-521830E4-5160-4E72-B14F-737F68DC499EQ34753820-8A309429-9374-4162-B100-7B5019781DD7Q34807135-9B0CD83C-5CAF-43E3-A28A-FBE46A05376BQ34965970-34538521-CE87-4ED6-B22F-1A6939C9F17AQ35145095-0BDC1207-96C8-4941-876E-38AB965A6580Q35596714-4BF958EF-D417-4E2D-8D29-7642EDF71ACFQ35673572-FEE359BC-D639-4C25-B540-528F2DADA9FAQ35827087-0322BAE9-04B1-484A-97E1-0DE6094E875FQ35848575-11EAAA6D-BD58-4E61-8075-50B7FFF030C4Q36545205-9516D1AE-B192-458F-8BA3-5DB7F73DCAC4Q37039657-E2FF080C-4795-4D5F-9765-D8597E65F663Q37269588-0E95DE41-883F-4FA3-A49D-AD7F97105024Q37317545-3B76B853-68C0-4D51-BD9B-95BBA0C1730CQ37406851-6CED42D1-D680-4039-9957-14D19681BB56Q37613072-545F59AA-DED7-4581-AA5B-06B16DDB53ABQ37619254-69B19291-A4BC-4E46-B88F-86A0999D8711Q37677267-33780328-E886-4F5F-9AB4-59831A589F54Q37694339-E52BD2F2-2AC7-4AAB-9A54-5059CBA13772Q37771259-6060493A-3614-4308-AF56-83BB123CA475Q38061224-5FCB8CA3-74AE-4CB7-A07E-225A64A8D518
P2860
Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Epithelial to mesenchymal tran ...... and aggressive tumor features.
@en
type
label
Epithelial to mesenchymal tran ...... and aggressive tumor features.
@en
prefLabel
Epithelial to mesenchymal tran ...... and aggressive tumor features.
@en
P2093
P2860
P50
P356
P1433
P1476
Epithelial to mesenchymal tran ...... and aggressive tumor features
@en
P2093
Adel K El-Naggar
Faye M Johnson
Gary E Gallick
Jeffery N Myers
Kazufumi Ohshiro
Randal S Weber
Scott M Lippman
P2860
P304
P356
10.1002/CNCR.23410
P407
P577
2008-05-01T00:00:00Z